Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Family Promoting Positive Emotions Pilot Study

31. januar 2023 oppdatert av: Autumn Kujawa, Vanderbilt University

Targeting Positive Emotions to Prevent Emotional Disturbances in Children During COVID-19

Anhedonia is characterized by loss of interest or pleasure. The proposed pilot study would be the first to test an innovative, neuroscience-informed intervention in mothers reporting depressive symptoms and stress to enhance positive emotionality with the goal of preventing anhedonia and associated emotional disturbances in their children. This study will recruit dyads (mothers and their children) for the intervention.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Anhedonia, characterized by loss of interest or pleasure, is a primary symptom of depression. Depression is increasingly prevalent and can cause significant impairments in life functioning. Given the increased presence of stress during COVID-19, there is a significant need for interventions that can prevent the development of anhedonia and depression. This study examines a neuroscience-informed positive emotion intervention to determine its effects on preventing anhedonia and associated emotional disturbances in dyads of children and their mothers. Participants will be randomized to either receive the positive emotion intervention for 8 sessions for 8 weeks with a clinician or the self-administered written information condition. Depressive symptoms, anhedonia, stress and other internalizing disorders will be assessed at baseline, and at the end of the intervention.

Studietype

Intervensjonell

Registrering (Faktiske)

74

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • Tennessee
      • Nashville, Tennessee, Forente stater, 37203
        • Vanderbilt University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

8 år og eldre (Barn, Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion criteria for mothers:

  • Age 18 and older who report at least subthreshold current depressive symptoms (> score of 8 on the Patient Health Questionnaire) and moderate COVID-19-related stress
  • Can read and speak in English.
  • Have access to a computer with a videoconferencing platform.

Inclusion criteria for children:

  • Age 8-12 years who can participate with their biological mother who is 18 years or older that meets the above criteria.
  • Can read and speak in English.

Exclusion criteria for mothers:

  • Current substance use disorder.
  • Intellectual disabilities.
  • Diagnosis of mania or bipolar disorder.
  • Diagnosis of a psychotic disorder (e.g., schizophrenia).
  • Visual or hearing impairments that interfere with completing study measures and sessions.

Exclusion criteria for children:

  • Diagnoses of autism spectrum disorders or developmental disorders.
  • Intellectual disabilities.
  • Diagnosis of mania or bipolar disorder.
  • Diagnosis of a psychotic disorder (e.g., schizophrenia).
  • Currently experiencing depressive symptoms.
  • Visual or hearing impairments that interfere with completing study measures and sessions.
  • Offspring of mothers who have previously participated in the study with another biological child.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Family Promoting Positive Emotions Group
Each dyad (mother and their child) will receive 8 sessions of promoting positive emotions intervention with a clinician for 8 weeks.
Atferdsmessig: Family Promoting Positive Emotions (F-PPE)
F-PPE is an 8-session dyadic intervention designed to enhance positive emotionality and buffer against the effects of stress on anhedonia in children. The intervention will be administered online through videoconferencing sessions with a clinician to mothers and their children.
Aktiv komparator: Written Information Group
Mothers will be sent written information and resources on depression for 8 weeks over email.
Atferdsmessig: Written Information
Mothers assigned to the Written Information condition will receive email newsletters providing resources relevant to depression.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Child perceived stress
Tidsramme: 8 weeks

The National Institutes of Health Toolbox Perceived Stress survey consists of 10 questions with options ranging in value from 1 to 5 to assess self-reported perceived stress for children (self- and parent-report). The minimum score is 10 and the maximum score is 50, with higher values meaning greater stress.

Hypothesis 1a: Children in the F-PPE group will show lower post-intervention perceived stress compared to the written information group.
8 weeks
Child emotional distress
Tidsramme: 8 weeks

The Patient-Reported Outcomes Measurement Information System (Anxiety, Depression, Anger) short form consists of questions with five response options ranging in value from 1 to 5 to assess self-reported anxiety, depression, anger and irritability for participants (parent, child, and parent report). Total scores on the emotional distress scales for children range from 33 to 165 for self-report and 26 to 130 for parent report, with higher scores reflect greater distress.

Hypothesis 1b: Children in the F-PPE group will show lower post-intervention emotional distress compared to the written information group.
8 weeks
Child positive affect
Tidsramme: 8 weeks

Positive affect will be assessed using the positive affect scale of the Positive and Negative Affect Schedule for Children administered through ecological momentary assessment over 10 days. Children rate their current affect on 5 items with a 1 to 5 scale for total scores from 5 to 25, with greater values reflecting greater positive affect.

Hypothesis 2a: Children in the F-PPE group will show relative increases in daily positive affect from pre- to post-intervention compared to the written information condition.

Hypothesis 2b: Changes in positive affect will partly account for F- PPE effects on child perceived stress and emotional distress.

Hypothesis 2c: Changes in positive affect will partly account for F- PPE effects on child perceived stress and emotional distress.
8 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Child reward learning
Tidsramme: 8 weeks

Reward learning will be measured using a Reinforcement Learning Task. The extent to which children begin to preferentially select the button that is more likely to be reinforced as a reward across the task will be used to quantify reinforcement learning.

Hypothesis 3a: Children in the F-PPE group will show relative increases in reward learning from pre- to post-intervention compared to the written information condition.

Hypothesis 3b: Changes in reward learning will partly account for F- PPE effects on child perceived stress and emotional distress.

Hypothesis 3c: Changes in reward learning will partly account for F- PPE effects on child perceived stress and emotional distress.
8 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Vanderbilt University

Samarbeidspartnere

American Psychological Foundation

Etterforskere

  • Hovedetterforsker: Autumn J Kujawa, PhD, Vanderbilt University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Hjelpsomme linker

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. desember 2021

Primær fullføring (Faktiske)

20. januar 2023

Studiet fullført (Faktiske)

20. januar 2023

Datoer for studieregistrering

Først innsendt

4. oktober 2021

Først innsendt som oppfylte QC-kriteriene

24. januar 2022

Først lagt ut (Faktiske)

4. februar 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. februar 2023

Siste oppdatering sendt inn som oppfylte QC-kriteriene

31. januar 2023

Sist bekreftet

1. januar 2023

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 211324

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Deidentified data will be available for sharing by request.

IPD-delingstidsramme

Immediately after publication.

Tilgangskriterier for IPD-deling

Principal investigator will review requests and grant access depending on the research question/plan and overlap with ongoing analyses in the laboratory.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere